Hexacycline

Broad-Spectrum Antibiotic • Respiratory Infection Treatment

TARGET ANIMAL

DESCRIPTION

Hexacycline Powder combines Doxycycline and Bromhexine to provide broad-spectrum antibacterial and mucoregulatory effects for respiratory and systemic infections.
Doxycycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, effectively targeting Gram-positive and Gram-negative bacteria, Mycoplasma, Chlamydia, Rickettsia, and certain protozoa.
Bromhexine improves airway clearance by stimulating mucus secretion and breaking down mucus fibers, enhancing lung function and antibiotic penetration.